Lyell Immunopharma, Inc. (LYEL)

23.21 -0.55 (-2.31%) USD  |  NASDAQ  |  Jan 20, 10:22
More

Lyell Immunopharma Cash from Discontinued Operations Adjustment (Quarterly)

Cash from Discontinued Operations Adjustment (Quarterly) Chart

View Cash from Discontinued Operations Adjustment (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Discontinued Operations Adjustment (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks
Start Trial
Insmed, Inc. --
Nektar Therapeutics --
GT Biopharma, Inc. --
Ionis Pharmaceuticals, Inc. --
Regeneron Pharmaceuticals, Inc. --